StockNews.com cut shares of Kewaunee Scientific (NASDAQ:KEQU – Free Report) from a strong-buy rating to a buy rating in a report released on Wednesday morning.
Kewaunee Scientific Price Performance
NASDAQ KEQU opened at $53.70 on Wednesday. The company has a 50 day simple moving average of $48.92 and a 200-day simple moving average of $39.90. Kewaunee Scientific has a 52-week low of $15.47 and a 52-week high of $55.62. The firm has a market capitalization of $152.51 million, a price-to-earnings ratio of 8.46 and a beta of 0.77. The company has a debt-to-equity ratio of 0.61, a current ratio of 2.28 and a quick ratio of 1.76.
Kewaunee Scientific (NASDAQ:KEQU – Get Free Report) last released its earnings results on Wednesday, June 26th. The technology company reported $1.55 earnings per share (EPS) for the quarter. Kewaunee Scientific had a net margin of 9.20% and a return on equity of 28.58%. The company had revenue of $56.70 million during the quarter.
Institutional Inflows and Outflows
About Kewaunee Scientific
Kewaunee Scientific Corporation designs, manufactures, and installs laboratory, healthcare, and technical furniture and infrastructure products. The company operates through two segments, Domestic and International. Its products include steel and wood casework, fume hoods, adaptable modular systems, moveable workstations, stand-alone benches, biological safety cabinets, and epoxy resin work surfaces and sinks.
See Also
- Five stocks we like better than Kewaunee Scientific
- Utilities Stocks Explained – How and Why to Invest in Utilities
- The Solar Stock Battle: Is Daqo or JinkoSolar Your Next Big Win?
- What is the Nikkei 225 index?
- Are These Chinese Stocks a Buy? Michael Burry’s Top Picks Say Yes
- What is the Dogs of the Dow Strategy? Overview and Examples
- Five Below Stock Faces Challenges Despite Strong Revenue Growth
Receive News & Ratings for Kewaunee Scientific Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Kewaunee Scientific and related companies with MarketBeat.com's FREE daily email newsletter.